Key Select Europe and Rest of the World (ROW) Markets and Products
Outside the U.S., our operations are primarily in Central
and Eastern Europe, including Croatia, Germany, Poland and Russia, where the markets vary considerably from the U.S.
market. For example, in many cases there is a market for branded generic products (i.e., generic products sold under
a company name) for which there are only limited opportunities for generic substitution by the pharmacist. As a result,
physician and pharmacist loyalty to a particular company's generic product can be a significant driver in obtaining
market share. In the recently expanded European Union (EU), as regulated by the European Medicine Agency (EMEA), the
EU's equivalent of the FDA, the generic pharmaceutical industry is becoming an increasingly important supplier of pharmaceuticals.
The Company's key European and ROW markets are:
Product Guide 
